MedWellAI, Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||
Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
Balance Sheet Date | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Sep-30 | 2015-Mar-31 | |||||||||
Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q4-FY2015 | |||||||||
Price to Sales | |||||||||||||||||||||||||||||||||||||||||||||||||
Forward Price to Sales MRQ | |||||||||||||||||||||||||||||||||||||||||||||||||
Price to Book | |||||||||||||||||||||||||||||||||||||||||||||||||
Price to Earnings | |||||||||||||||||||||||||||||||||||||||||||||||||
Forward Price to Earnings MRQ | |||||||||||||||||||||||||||||||||||||||||||||||||
Debt to Asset Ratio | 3.90x | 1.64x | 1.38x | 1.12x | .93x | 1.25x | 1.31x | 1.25x | 1.08x | .50x | .45x | .38x | .35x | .05x | .04x | .03x | .02x | .06x | 1.28x | 1.45x | 1.20x | 1.00x | .96x | 1.03x | 1.97x | .93x | .82x | 1.16x | 3.57x | .16x | .42x | 1.12x | 1.17x | 25.51x | 21.08x | 54.53x | 183.75x | 25.55x | .46x | 2.43x | |||||||||
Current Ratio | .14x | .25x | .40x | .47x | .71x | .61x | .01x | .02x | .24x | .11x | .03x | .08x | .32x | .05x | .29x | 1.81x | 40.38x | 8.48x | .10x | .16x | .02x | .12x | .08x | .06x | .04x | .15x | .14x | .15x | .06x | 4.32x | .94x | .38x | .85x | .03x | .04x | .01x | - | .03x | 1.29x | .25x |